Renal cystic disease in tuberous sclerosis complex

Exp Biol Med (Maywood). 2021 Oct;246(19):2111-2117. doi: 10.1177/15353702211038378. Epub 2021 Sep 6.

Abstract

Tuberous sclerosis complex (TSC) is associated with TSC1 or TSC2 gene mutations resulting in hyperactivation of the mTORC1 pathway. This mTORC1 activation is associated with abnormal tissue development and proliferation such that in the kidney there are both solid tumors and cystic lesions. This review summarizes recent advances in tuberous sclerosis complex nephrology and focuses on the genetics and cell biology of tuberous sclerosis complex renal disease, highlighting a role of extracellular vesicles and the innate immune system in disease pathogenesis.

Keywords: Tuberous sclerosis complex; cell nonautonomous trait; extracellular vesicles; renal cysts.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Humans
  • Immunity, Innate / genetics
  • Kidney / pathology
  • Kidney Diseases / genetics*
  • Kidney Diseases / pathology
  • Mutation / genetics
  • Signal Transduction / genetics
  • Tuberous Sclerosis / metabolism*
  • Tumor Suppressor Proteins / genetics*

Substances

  • Tumor Suppressor Proteins